rs763471784
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000057.4(BLM):c.2672G>A(p.Gly891Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G891R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000057.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Bloom syndrome Pathogenic:1Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 891 of the BLM protein (p.Gly891Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Bloom syndrome (PMID: 17407155). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 524780). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt BLM protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects BLM function (PMID: 17878217). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.G891E variant (also known as c.2672G>A), located in coding exon 13 of the BLM gene, results from a G to A substitution at nucleotide position 2672. The glycine at codon 891 is replaced by glutamic acid, an amino acid with similar properties. This variant was observed in a compound heterozygous individual affected with Bloom Syndrome (German J et al. Hum. Mutat., 2007 Aug;28:743-53). Structural modeling of the p.G891E variant on the BLM helicase domain predicts that this variant will abolish both ATPase and DNA unwinding activities of BLM protein (Rong SB et al. Mol. Med., 2000 Mar;6:155-64). An in-depth in vitro analysis for BLM function in this variant showed a strong reduction in helicase, ATPase, and DNA binding activities, but no deficiency in ATP binding (Guo RB et al. Nucleic Acids Res., 2007 Sep;35:6297-310). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at